Suchergebnisse - "Zhang, Li"

PubPharm (5)

1

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer : Predictors for response and prognosis

enthalten in: Thoracic cancer | 2021

von Zhu, H. | Liu, Y. | Feng, Y. | +7

2

Occurrence of hypertension during third-line anlotinib is associated with progression-free survival in patients with squamous cell lung cancer (SCC) : A post hoc analysis of the ALTER0303 trial

enthalten in: Thoracic cancer | 2021

von Shi, J. | Chen, G. | Wang, H. | +18

3

Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy : A multicenter prospective cohort study

enthalten in: Thoracic cancer | 2020

von Ai, B. | Zhang, L. | Huang, D. | +7

4

Efficacy and safety of immune checkpoint inhibitor consolidation after chemoradiation in patients of Asian ethnicity with unresectable stage III non-small cell lung cancer : Chinese multicenter report and literature review

enthalten in: Thoracic cancer | 2020

von Zhang, T. | Xu, K. | Bi, N. | +8

5

Establishment of a prospective multicenter cohort for advanced non-small cell lung cancer in China (CAPTRA-Lung study)

enthalten in: Thoracic cancer | 2018

von Xu, Y. | Zhang, L. | Fang, J. | +17

1
[1]